A 65-year-old male with severe biventricular heart failure is receiving an intravenous infusion of milrinone. What is the primary mechanism of action responsible for its inotropic and vasodilatory effects?
-
A
Stimulation of beta-1 adrenergic receptors, increasing intracellular cAMP.
-
B
Inhibition of phosphodiesterase-3 (PDE3), leading to increased intracellular cAMP.
-
C
Blockade of voltage-gated calcium channels, causing smooth muscle relaxation.
-
D
Sensitization of the contractile apparatus to calcium, without increasing intracellular calcium levels.